Abbott India has appointed Prithwish Kumar Banerji as Commercial Director - Women`s Health, Metabolics and International Business with effect from 03 January 2025.Powered by Capital Market - Live News

Abbott India announced that Murari Ranganathan, Commercial Director - Women`s Health, Metabolics and International Business, has tendered his resignation from employment of the Company with effect from close of business hours of 25 February 2025. Powered by Capital Market - Live News

The Board of Abbott India at its meeting held on 07 November 2024 has approved the appointment of Sridhar Kadangode (DIN: 06715478) as an Additional Director of the Company with effect from 07 November 2024. Powered by Capital Market - Live News

Net profit of Abbott India rose 14.59% to Rs 358.61 crore in the quarter ended September 2024 as against Rs 312.94 crore during the previous quarter ended September 2023. Sales rose 9.27% to Rs 1632.67 crore in the quarter ended September 2024 as against Rs 1494.14 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1632.671494.14 9 OPM %26.8925.49 - PBDT496.94433.26 15 PBT479.43415.42 15 NP358.61312.94 15 Powered by Capital Market - Live News

Abbott India will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live News